Strategic acquisition strengthens UK life science reach

Europa Biosite has expanded its UK footprint by acquiring Stratech Scientific, integrating the long-established life science distributor with its subsidiary, Cambridge Bioscience. The move broadens Europa Biosite’s product offering and extends its reach across academic and biopharma research communities.

“After 43 years leading Stratech Scientific, I am delighted to join forces with Europa Biosite,” said Sue Hallett, Managing Director of Stratech Scientific. “By combining our portfolios and customer reach with Cambridge Bioscience, we can provide researchers with a broader range of products and even stronger service, while creating new opportunities for our suppliers.”

Tim Hiddemann, CEO of Europa Biosite, added: “Integrating Stratech Scientific’s established product lines and customer relationships with Cambridge Bioscience reinforces our UK market position. This acquisition aligns with our ambition to offer the most comprehensive life science reagent portfolio in Europe and to strengthen relationships with suppliers and researchers.”

The acquisition brings together two complementary portfolios, providing UK researchers with an expanded catalogue and greater national coverage. Europa Biosite continues its pan-European growth strategy through targeted acquisitions, reinforcing its position as a leading distributor of high-quality life science research products.

Financial terms of the transaction were not disclosed.

More information online